Skip to main content
APTAMER GROUP PLC logo

APTAMER GROUP PLC — Investor Relations & Filings

Ticker · APTA ISIN · GB00BNRRP542 LEI · 213800Y4XGH3WJNBE686 IL Professional, scientific and technical activities
Open in API
Filings indexed 202 across all filing types
Latest filing 2025-01-28 Remuneration Information
Country GB United Kingdom
Listing IL APTA

About APTAMER GROUP PLC

https://aptamergroup.com/

Aptamer Group PLC is a life sciences company that develops custom affinity binders to address targeting challenges in research, diagnostics, and therapeutics. The company's core technology is the Optimer® platform, which discovers and develops proprietary, next-generation aptamer-based binders. These Optimer binders are engineered for high specificity, stability, and manufacturability. The company provides custom development services, partnering with global pharmaceutical, diagnostic, and biotechnology organizations to support their programs from early discovery through to clinical development. Key application areas include the development of novel therapeutics, advanced diagnostic assays, bioprocessing workflows, and biomarker discovery.

Recent filings

Filing Released Lang Actions
Issue of Equity in lieu of Director fees
Remuneration Information Classification · 99% confidence The document is an official announcement released via RNS (RNS Number: 0031V) on January 28, 2025. The core content details the 'Issue of Equity in lieu of Director fees' for a Non-Executive Director (Tim Sykes) and provides mandatory disclosures under the UK Market Abuse Regulation regarding transactions by Persons Discharging Managerial Responsibilities (PDMRs). This is a specific regulatory disclosure concerning insider transactions and share issuance related to compensation, not a comprehensive financial report (like 10-K or IR) or a general meeting material. While it involves share issuance (SHA) and director dealings (DIRS), the primary context is the formal notification of a transaction by a director/PDMR, which aligns closely with the scope of Director's Dealing (DIRS). However, the structure, the explicit mention of RNS, and the nature of the disclosure (transaction notification) make it a specific regulatory filing. Since the transaction involves the issuance of shares to a director to settle fees, it is a hybrid. Given the explicit table format for PDMR transactions and the focus on director dealings, DIRS is a strong candidate. However, the document also explicitly mentions 'Director fee shares' and the total voting rights change, which is a share capital change. Since the primary action is the notification of a director's transaction/holding change, DIRS is the most specific fit among the options that cover insider activity. If DIRS were not available, it might fall under RNS or SHA. Given the detailed PDMR disclosure section, DIRS is the best fit.
2025-01-28 English
Half Year Trading Update
Earnings Release Classification · 99% confidence The document is titled 'Half Year Trading Update' and provides unaudited revenue figures (£0.7 million for H1 25) and order book details for the six months ending 31 December 2024. This content structure—a summary of financial performance for a period shorter than a full year, often released before a full quarterly/interim report—strongly suggests an Earnings Release (ER) or an Interim Report (IR). Since it is explicitly a 'Trading Update' focusing on key financial highlights and operational progress for a half-year period, it aligns best with the definition of an Earnings Release (ER), which is the initial announcement of periodical financial results (key highlights only). It is not a comprehensive Interim Report (IR) which would typically be more detailed, nor is it a full Annual Report (10-K). The presence of the RNS Number and the closing statement referencing RNS confirms it is a regulatory announcement, but the content dictates the specific type. H1 2025
2025-01-28 English
Notification of dealings by a director/PDMR
Director's Dealing Classification · 100% confidence The document is a formal notification titled "Notification of dealings by a director/PDMR" concerning the purchase of shares by a Non-Executive Director, Tim Sykes. It explicitly references compliance with the UK Market Abuse Regulation and details the transaction (price, volume, date). This type of filing, reporting personal share transactions by company directors and executives, directly corresponds to the definition of Director's Dealing (DIRS). Although it carries an RNS number, the specific content overrides the general RNS fallback.
2025-01-13 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is clearly identified by the header 'RNS Number : 5358R' and contains the standard boilerplate text indicating it is provided by RNS, the news service of the London Stock Exchange. The content itself is a 'TR-1: Standard form for notification of major holdings' detailing an acquisition of voting rights by Dowgate Group Limited, crossing the 5% threshold. This type of regulatory filing concerning changes in significant share ownership aligns directly with the definition for Major Shareholding Notification (MRQ). Although it is an RNS filing, MRQ is the more specific category for this content type.
2024-12-30 English
Notification of dealings by a director/PDMR
Director's Dealing Classification · 100% confidence The document is an official notification disseminated via RNS (RNS Number : 8247Q) concerning a transaction by a Person Discharging Managerial Responsibilities (PDMR), specifically the Chief Scientific Officer, David Bunka, purchasing company shares. The structure, content (including tables detailing the transaction, instrument, price, volume, and date), and explicit reference to 'UK Market Abuse Regulation' clearly indicate this is a regulatory filing related to insider trading or director dealings. This matches the definition for Director's Dealing (DIRS).
2024-12-19 English
New Development Contract
Regulatory Filings Classification · 98% confidence The document begins with 'RNS Number : 6662Q' and is dated '19 December 2024'. It announces a 'New Development Contract' and includes contact information for Investor Relations and Brokers, concluding with standard disclaimers from RNS, the news service of the London Stock Exchange, which states it is an 'approved Primary Information Provider'. This structure is characteristic of a general regulatory news announcement disseminated via the RNS system, rather than a specific financial report (like 10-K or IR) or a dedicated announcement type (like DIV or ER). Since it is a general regulatory announcement that doesn't fit the more specific categories, the fallback code 'RNS' is appropriate.
2024-12-19 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.